4/A: DENTSPLY SIRONA Director Buys Shares

DENTSPLY SIRONA Inc. reports a Form 4 filing detailing a stock purchase by Director Jonathan Jay Mazelsky.

Summary

• Jonathan Jay Mazelsky, a Director at DENTSPLY SIRONA Inc., acquired 10,000 shares of common stock on June 12, 2026.
• The purchase was made at a price of $10.14 per share, totaling $101,400.
• Following this transaction, Mazelsky beneficially owns 61,668.534 shares of common stock directly.
• This filing is an amendment to a previous Form 4 filed on June 15, 2026, correcting the transaction code from 'A' to 'P' to accurately reflect an open market purchase.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing due to the insider purchase, indicating confidence, though it's a routine disclosure of a transaction.

Positives

• Director Jonathan Jay Mazelsky's purchase of company stock indicates confidence in the company's future prospects.
• The acquisition of 10,000 shares demonstrates a direct investment by a key insider.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing, which primarily reports a past transaction.

Industry Context

StockSavvy.ai notes that insider stock purchases, particularly by directors, are often viewed positively by the market as they signal management's belief in the company's intrinsic value and future growth potential. This type of transaction is common across the medical device and healthcare technology sectors.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive signal of confidence in the company's performance and future value.
• Employees may be encouraged by the commitment shown by leadership through direct investment.

Key Dates

Recommendation

This filing is a routine disclosure of an insider stock purchase and does not contain information that would warrant a change in investment strategy. While the purchase signals confidence, it does not provide new strategic or financial information to alter a 'hold' position.

Keywords

DENTSPLY SIRONA, XRAY, Form 4, Insider Trading, Stock Purchase, Director, Beneficial Ownership, SEC Filing